Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIVALIRUDIN vs BOCOCIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BIVALIRUDIN vs BOCOCIZUMAB: Safety Overview

Metric BIVALIRUDIN BOCOCIZUMAB
Total FAERS Reports 839 122
Deaths Reported 137 1
Death Rate 16.3% 0.8%
Hospitalizations 249 114
Average Patient Age 53.2 yrs 61.8 yrs
% Female Patients 33.7% 27.1%
FDA Approval Date Dec 15, 2000 N/A
Manufacturer Meitheal Pharmaceuticals Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A